Skip to main content
SpringerLink
Log in

Polymorphic markers associated with genes responsible for lipid and carbohydrate metabolism disorders and insulin resistance in cancer patients

  • Genomics. Transcriptomics. Proteomics
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

Glucose intolerance and insulin resistance are among the leading risk factors for breast (BC) and endometrial cancer (EC). Differences in the degree of association of these endocrine disorders with BC and EC can at least partly be explained by the diverse polygenic nature of the aforementioned metabolic shifts as well as of oncological diseases themselves. In 105 healthy postmenopausal women and 301 female cancer patients (110 BC and 191 EC) without overt diabetes mellitus, we compared the frequencies of the following genetic polymorphisms: insulin receptor substrate-1, IRS Gly972Arg; leptin receptor, LEPR Lys109Arg and Gln223Arg; mitochondrial uncoupling protein-2, UCP2_866G/A; and the ND3 gene of mitochondrial DNA, mtDNA 10398A/G. Genotyping was performed by allele-specific real-time PCR. The heterozygous genotype Gln/Arg of the Gln223Arg polymorphism in LEPR and the combination of the Gln/Arg and Gln/Gln genotypes proved to be associated with elevated risks of both BC (OR Gln/Arg = 2.03 (CI = 1.08–3.81), p = 0.027; OR Gln/Arg+Gln/Gln = 1.87 (CI = 1.02–3.43), p = 0.042) and EC ( OR Gln/Gln = 2.05 (CI = 1.00–4.17), p = 0.046, OR Gln/Arg = 1.88 (CI = 1.07–3.28), p = 0.026). Other markers (genotype UCP2_866AA and mtDNA polymorphism 10398A) appeared to be relatively more frequent in EC than in BC, which may account for lower insulin sensitivity and higher incidence of carbohydrate metabolism disorders in EC cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dil’man V.M. 1987. Chetyre modeli meditsiny (Four Models of Medicine). Leningrad: Meditsina.

    Google Scholar 

  2. Dedov I.I., Shestakova M.N. 2003. Sakharnyi diabet (Diabetes Mellitus). Moscow: Universum Publ.

    Google Scholar 

  3. Iozzo P., Beck-Nielsen H., Laakso M., et al. 1999. Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J. Clin. Endocrinol. Metab. 84, 863–868.

    Article  PubMed  CAS  Google Scholar 

  4. Berstein L.M. 2005. Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer. Cancer Lett. 224, 203–212.

    Article  PubMed  CAS  Google Scholar 

  5. Goodwin P.J., Ennis M., Pritchard K.I., et al. 2002. Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J. Clin. Oncol. 20, 42–51.

    Article  PubMed  CAS  Google Scholar 

  6. Silvera S.A., Jain M., Howe G.R., et al. 2005. Dietary carbohydrates and breast cancer risk: A prospective study of the roles of overall glycemic index and glycemic load. Int. J. Cancer. 114, 653–658.

    Article  PubMed  CAS  Google Scholar 

  7. Eckel R.H., Grundy S.M., Zimmet P.Z. 2005. The metabolic syndrome. Lancet. 365, 1415–1428.

    Article  PubMed  CAS  Google Scholar 

  8. Reaven G.M. 2003. The insulin resistance syndrome. Curr. Atheroscler. Rep. 5, 364–371.

    Article  PubMed  Google Scholar 

  9. Lawlor D.A., Smith G.D., Ebrahim S. 2004. Hyperinsulinaemia and increased risk of breast cancer: Findings from the British Women’s Heart and Health Study. Cancer Causes Control. 15, 267–275.

    Article  PubMed  Google Scholar 

  10. Calle E.E., Thun M.J. 2004. Obesity and cancer. Oncogene. 23, 6365–6378.

    Article  PubMed  CAS  Google Scholar 

  11. Bershtein L.M. 2004. Onkoendokrinologiya: traditsii, sovremennost’ i perspektivy (Oncoendocrinology: Traditions, Current State, and Prospects). St. Petersburg: Nauka.

    Google Scholar 

  12. Vogelstein B., Kinzler K.W. 2004. Cancer genes and the pathways they control. Nature Med. 10, 789–799.

    Article  PubMed  CAS  Google Scholar 

  13. Wood L.D., Parsons D.W., Jones S., et al. 2007. The genomic landscapes of human breast and colorectal cancers. Science. 318, 1108–1113.

    Article  PubMed  CAS  Google Scholar 

  14. Imyanitov E.N., Togo A.V., Hanson K.P. 2004. Searching for cancer-associated gene polymorphisms: promises and obstacles. Cancer Lett. 204, 3–14.

    Article  PubMed  CAS  Google Scholar 

  15. Kaplan J.C., Junien C. 2000. Genomics and medicine: an anticipation. From Boolean Mendelian genetics to multifactorial molecular medicine. C.R. Acad. Sci. III. 323, 1167–1174.

    PubMed  CAS  Google Scholar 

  16. Laakso M. 2004. Gene variants, insulin resistance, and dyslipidaemia. Curr. Opin. Lipidol. 15, 115–120.

    Article  PubMed  CAS  Google Scholar 

  17. Loktionov A. 2003. Common gene polymorphisms and nutrition: Emerging links with pathogenesis of multifactorial chronic diseases (review). J. Nutr. Biochem. 14, 426–451.

    Article  PubMed  CAS  Google Scholar 

  18. Liou C.-W., Lin T.-K., Weng H.H., et al. 2007. A common mitochondrial DNA variant and increased body mass index as associated factors for development of type 2 diabetes: Additive effects of genetic and environmental factors. J. Clin. Endocr. Metabol. 92, 1235–1239.

    Article  Google Scholar 

  19. Gaziev A.I., Podlutskii A.Ya. 2003. Low efficiency of mitochondrial DNA repair system. Tsitologiya. 45, 403–417.

    CAS  Google Scholar 

  20. Skulachev V.P. 1999. Mitochondrial physiology and pathology; Concepts of programmed death of organelles, cells and organisms. Mol. Aspects Med. 20, 139–184.

    Article  PubMed  CAS  Google Scholar 

  21. Wallace D.C. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359–407.

    Article  PubMed  CAS  Google Scholar 

  22. Jellema A., Zeegers M.P., Feskens E.J., et al. 2003. Gly972Arg variant in the insulin receptor substrate-1 gene and association with type 2 diabetes: A meta-analysis of 27 studies. Diabetologia. 46, 990–995.

    Article  PubMed  CAS  Google Scholar 

  23. Salopuro T., Pulkkinen L., Lindstrom J., et al. 2005. Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study. Int. J. Obes.(Lond). 29, 1245–1251.

    Article  CAS  Google Scholar 

  24. Müllenbach R., Lagoda P.J., Welter C. 1989. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet. 5, 391–397.

    PubMed  Google Scholar 

  25. Shamanina M.Yu., Vavilin V.A., Mordvinov V.A., et al. 2007. Polymerase chain reaction with real-time detection and its possible clinical applications. Vestn. Ross. Akad. Med. Nauk. 7, 37–26.

    PubMed  Google Scholar 

  26. Zaggini A., Waadin I.N., Lindgran C.H., et al. 2007. Replication of genome-wide association signals in UK samples reveals risk leci for type 2 diabetes. Science. 316, 1336–1341.

    Article  Google Scholar 

  27. Hoffmann K., Mattheisen M., Dahm S., et al. 2007. A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2. Diabetologia. 50, 1418–1422.

    Article  PubMed  CAS  Google Scholar 

  28. Richardson L.C., Pollack L.A. 2005. Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nature Clin. Pract. Oncol. 2, 48–53.

    Article  Google Scholar 

  29. Bershtein L.M., Merabishvili V.M., Semenova N.V., et al. 2007. Population analysis of combined cancer and diabetes mellitus: Frequency and specific features. Vopr. Onkol. 53, 285–290.

    PubMed  CAS  Google Scholar 

  30. Slattery M.L., Samowitz W., Curtin K., et al. 2004. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol. Bio-markers Prev. 13, 1206–1214.

    CAS  Google Scholar 

  31. Snoussi K., Strosberg A.D., Bouaouina N., et al. 2006. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 6, 38.

    Article  PubMed  Google Scholar 

  32. Portolés O., Sorli J.V., Francés F., et al. 2006. Effect of genetic variation in the leptin gene promoter and the leptin receptor gene on obesity risk in a population-based case-control study in Spain. Eur. J. Epidemiol. 21, 605–612.

    Article  PubMed  Google Scholar 

  33. Rai E., Sharma S., Koul A., et al. 2007. Interaction between the UCP2-866G/A, mtDNA 10398G/A and PGC1alpha p.Thr394Thr and p.Gly482Ser polymorphisms in type 2 diabetes susceptibility in North Indian population. Hum. Genet. 122, 535–540.

    Article  PubMed  CAS  Google Scholar 

  34. Bai R.K., Leal S.M., Covarrubias D., et al. 2007. Mitochondrial genetic background modifies breast cancer risk. Cancer Res. 67, 4687–4694.

    Article  PubMed  CAS  Google Scholar 

  35. Fan J., McKean-Cowdin R., Bernstein L., et al. 2006. An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivors. Breast Cancer Res. Treat. 99, 323–331.

    Article  PubMed  CAS  Google Scholar 

  36. Canter J.A., Kallianpur A.R., Parl F.F., Millikan R.C. 2005. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 65, 8028–8033.

    PubMed  CAS  Google Scholar 

  37. Yu Y., Hao Y., Feig L.A. 2006. The R-Ras GTPase mediates cross talk between estrogen and insulin signaling in breast cancer cells. Mol. Cell. Biol. 26, 6372–6380.

    Article  PubMed  CAS  Google Scholar 

  38. Maeso Fortuny M.C., Brito Diaz B., Cabrera de León A. 2006. Leptin, estrogens and cancer. Mini Rev. Med. Chem. 6, 897–907.

    Article  PubMed  CAS  Google Scholar 

  39. Louet J.F., LeMay C., Mauvais-Jarvis F. 2004. Antidiabetic actions of estrogen: Insight from human and genetic mouse models. Curr. Atheroscler Rep. 6, 180–185.

    Article  PubMed  Google Scholar 

  40. Yager J.D., Davidson N.E. 2006. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354, 270–282.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Petrov Research Institute of Oncology, St.-Petersburg, 197758, Russia

    Yu. M. Ulybina, E. N. Imyanitov, D. A. Vasilyev & L. M. Berstein

Authors
  1. Yu. M. Ulybina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. N. Imyanitov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. A. Vasilyev
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. M. Berstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. M. Berstein.

Additional information

Original Russian Text © Yu.M. Ulybina, E.N. Imyanitov, D.A. Vasilyev, L.M. Berstein, 2008, published in Molekulyarnaya Biologiya, 2008, Vol. 42, No. 6, pp. 945–953.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ulybina, Y.M., Imyanitov, E.N., Vasilyev, D.A. et al. Polymorphic markers associated with genes responsible for lipid and carbohydrate metabolism disorders and insulin resistance in cancer patients. Mol Biol 42, 843–851 (2008). https://doi.org/10.1134/S0026893308060034

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893308060034

Key words

Search

Navigation